Showing results (1601-1610 of 1,613) with videos related to

Sort By:
Pageof 162
Chinese Journal of Integrative Medicine|October 10, 2020
Efficacy of Getong Tongluo Capsule () for Convalescent-Phase of Ischemic Stroke and Primary Hypertension: A Multicenter, Randomized, Double-Blind, Controlled TrialQian-Yu Zhao, Rong-Hua Tang, Guo-Xiong Lu, et al.
The New England Journal of Medicine|January 24, 2020
Elagolix for Heavy Menstrual Bleeding in Women with Uterine FibroidsWilliam D Schlaff, Ronald T Ackerman, Ayman Al-Hendy, et al.
Journal of Cancer|September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective StudyQi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.
Brain Circulation|August 22, 2025
External validation of N2H3 nomogram to predict outcomes in patients with acute ischemic stroke treated by intravenous thrombolysisHuai-Mei Zhang, Zi-Duo Shen, Yang Qu, et al.
Military Medical Research|March 5, 2025
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver diseaseGuo-Lin Miao, Wen-Xi Zhang, Yi-Tong Xu, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|October 17, 2020
[Moxibustion therapy in prevention and treatment of coronavirus disease 2019 (COVID-19): construction and application of non-contact diagnosis and treatment mode]Xia Chen, Wei Huang, Bao-Yan Liu, et al.
The New England Journal of Medicine|January 25, 2018
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 InfectionStefan Zeuzem, Graham R Foster, Stanley Wang, et al.
Annals of the Rheumatic Diseases|March 5, 2024
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre studyAndrea Di Matteo, Gianluca Smerilli, Stefano Di Donato, et al.
Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.
JAMA|March 13, 2025
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical TrialYe-Lin Liang, Xu Liu, Liang-Fang Shen, et al.
Pageof 162